New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
08:13 EDTMRShort reports on Mindray Medical create buying opportunity, says Oppenheimer
Oppenheimer believes that Mindray's fundamentals are improving, and it expects the company's profits to rise 10.9% in FY14. The firm keeps an Outperform rating on the shares.
News For MR From The Last 14 Days
Check below for free stories on MR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 11, 2014
17:14 EDTMRMindray Medical sees FY14 revenue up 10% vs. FY13
The company now also anticipates its Fy14 non-GAAP net income to decrease by a mid-single-digit percentage over its FY13 non-GAAP net income. This guidance excludes the tax benefits related to the nationwide key software enterprise status and assumes a corporate income tax rate of 15% applicable to the Shenzhen subsidiary.
17:11 EDTMRMindray Medical reports Q2 EPS 54c, consensus 54c
Reports Q2 revenue $334.5M, consensus $348.3M.
15:32 EDTMRNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Ventas (VTR), consensus $1.09; Nuance Communications (NUAN), consensus 27c; Intercept Pharmaceuticals (ICPT), consensus (12c); Rackspace Hosting (RAX), consensus 16c; Opko Health (OPK), consensus (9c); Mindray Medical (MR), consensus 54c; Chimera Investment (CIM), consensus 9c; Globalstar (GSAT), one estimate (4c); 51job (JOBS), consensus 32c; Dealertrack Technologies (TRAK), consensus 373c; Caesars Entertainment (CZR), consensus ($1.19); Towerstream (TWER), consensus (10c); Resolute Energy (REN), consensus 1c; Forest Oil (FST), consensus (2c).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use